Hyphens Pharma International Limited - Laporan Laba Rugi (TTM)

Hyphens Pharma International Limited
SGD 0.34 ↓ -0.00 (-1.45%)
2025-09-04
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Hyphens Pharma International Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 126 121 126 123 126 126 132 143 156 162 156 156 156 171 185 196 197 195 192 185
Change (%) -3.84 4.19 -2.30 2.23 -0.01 4.86 8.17 9.54 3.78 -3.66 -0.04 0.04 9.09 8.65 5.49 0.55 -0.60 -1.65 -3.58
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 83 79 83 78 80 78 82 89 96 100 96 97 99 110 120 128 127 127 125 119
Change (%) -4.56 4.69 -6.37 3.11 -2.21 4.10 9.25 7.68 4.10 -4.02 1.01 2.30 10.44 9.54 6.66 -0.82 0.17 -1.67 -5.10
% of Revenue 66.12 65.63 65.94 63.20 63.74 62.34 61.89 62.51 61.45 61.63 61.40 62.04 63.44 64.23 64.75 65.47 64.58 65.08 65.06 64.04
Gross Operating Profit 43 42 43 45 46 47 50 54 60 62 60 59 57 61 65 68 70 68 67 67
Change (%) -2.44 3.23 5.57 0.72 3.86 6.12 6.41 12.64 3.28 -3.07 -1.70 -3.65 6.74 7.05 3.34 3.15 -2.00 -1.60 -0.76
% of Revenue 33.88 34.37 34.06 36.80 36.26 37.66 38.11 37.49 38.55 38.37 38.60 37.96 36.56 35.77 35.25 34.53 35.42 34.92 34.94 35.96
SG&A 36 37 37 39 37 40 40 43 40 48 48 48 48 50 50 52 50 55 69 57
Change (%) 1.67 0.00 6.59 -6.18 8.07 0.00 9.00 -8.26 20.72 0.00 1.24 -1.23 4.57 -0.13 4.85 -4.63 9.92 25.24 -17.69
% of Revenue 28.66 30.30 29.09 31.73 29.12 31.47 30.01 30.25 25.33 29.47 30.58 30.98 30.58 29.32 26.95 26.79 25.41 28.10 35.78 30.54
R&D
Change (%)
% of Revenue
OpEx 119 116 120 117 120 118 123 132 142 148 145 145 148 160 172 180 182 182 180 175
Change (%) -2.68 3.21 -2.40 2.91 -1.84 3.86 7.98 7.37 4.00 -2.28 0.62 1.88 7.73 8.01 4.66 1.05 -0.11 -1.18 -2.59
% of Revenue 94.78 95.93 95.03 94.93 95.56 93.81 92.91 92.75 90.91 91.10 92.40 93.02 94.72 93.54 92.99 92.26 92.72 93.17 93.62 94.58
Operating Income 7 5 6 6 6 8 9 10 14 14 12 11 8 11 13 15 14 13 12 10
Change (%) -25.00 27.32 -0.38 -10.43 39.30 20.07 10.63 37.34 1.65 -17.77 -8.09 -24.41 33.44 18.00 16.50 -5.46 -6.83 -8.01 -18.11
% of Revenue 5.22 4.07 4.97 5.07 4.44 6.19 7.09 7.25 9.09 8.90 7.60 6.98 5.28 6.46 7.01 7.74 7.28 6.83 6.38 5.42
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1
Change (%) 0.92 -0.00 -2.73 2.80 -13.64 -0.00 18.95 -15.93 150.53 -0.00 37.39 -27.22 16.81 -0.00 15.83 -13.66 103.24 26.46 -6.93
% of Revenue -0.09 -0.09 -0.09 -0.09 -0.09 -0.08 -0.07 -0.08 -0.06 -0.15 -0.15 -0.21 -0.15 -0.16 -0.15 -0.16 -0.14 -0.29 -0.37 -0.36
Net Income 7 6 6 6 6 7 8 9 12 11 10 9 7 9 10 10 10 10 8 6
Change (%) -9.29 0.19 0.34 3.92 6.32 15.51 9.93 34.90 -3.21 -16.03 -8.13 -23.18 27.37 15.71 5.06 -0.03 -2.10 -18.48 -22.26
% of Revenue 5.40 5.09 4.90 5.03 5.11 5.44 5.99 6.09 7.50 6.99 6.10 5.60 4.30 5.02 5.35 5.33 5.30 5.22 4.32 3.49

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista